Recent Articles
Research Symposium shines light on child...
September is Childhood Cancer Awareness ...
Australian research paves way for new ca...
World-first study into precision medicin...
The bittersweet story of childhood leuka...
Surviving sarcoma: Ashleigh’s story
Immunotherapy for children with sarcoma
Day in the life: brain cancer researcher
Brain cancer in focus: An introduction
Zero Childhood Cancer precision medicine...
Celebrating International Women's Day
Our new virtual lab tour
Madeleine's Diary of a Researcher
Fast-tracking new treatments into clinic...
Australian researchers find new way to t...
'Outstanding' childhood cancer scientist...
Opening the black box of childhood cance...
Zero Childhood Cancer: How far have we c...
Awareness Wednesday: Discover and Transl...
Finding new treatments for those who nee...
Blocking copper uptake in tumour cells m...
Spotlight: Sarcoma in kids
Targeting stem cells: the path to curing...
Australia to lead world-first trial in c...
Nanomedicine for brain cancer – a worl...
In focus: Brain cancer in kids
Science spotlight: Minimal Residual Dise...
Diary of a Researcher
Science spotlight: Metallomics
An update on our life-saving research
Research boosts progress towards persona...
International research collaboration rev...
New therapy shows ‘dramatic’ effect ...
Neuroblastoma research points to new pos...
Researchers find new way to target child...
Our New Research Structure
Awareness Wednesday: Immunotherapy
DIPG: Shining A Light On The Deadliest C...
New gene found for a deadly childhood ca...
New Gene Found in Neuroblastoma Offers P...
Australian researchers find chink in the...
Anticancer Drug CBL0137 Highly Effective...
New research paves the way for safer leu...
Science Spotlight: Leukaemia Stem Cells
Meet new Team Leader, Dr Charles de Bock
Our researchers combine an old drug with...
Australian Scientists Discover a Potenti...
Fundamental mechanism behind chemotherap...
Partnerships: Cancer Therapeutics CRC
How Targeting Copper Levels in Tumours C...
New Drug OBI-3424 An ‘Orphan Drug’ T...
New imaging method could help treat and ...
Awareness Wednesday: Drug Discovery
Awareness Wednesday: Cancer Genomics
Tracking cancer with gold-coated nanopar...
A global effort to improve childhood can...
Nano-stars – targeting a deadly childh...
We’ve created our road map for the nex...
Forging new alliances to tackle childhoo...
The past, present and future for young A...
New hope for children's brain cancer
Reining In A Runaway Gene In Neuroblasto...
Zero Childhood Cancer national clinical ...
Sydney researchers find a way to target ...
It’s in the Delivery: Researchers Find...
Opening doors to a world of scientific e...
VR helps scientists ‘walk’ through c...
How specific DNA ‘microdeletions’ he...
How do clinical trials work?
We made great strides with childhood leu...
Potential Leukaemia Drug Excites Interna...
Resistance is Futile: The MRP1 Story
How a Dad's Insights can Help Research
Awareness Wednesday: the Future of Child...
Awareness Wednesday: going into clinic
Children with most aggressive cancers to...
Awareness Wednesday: Starting with the B...
When I grow up, I want to cure cancer
Childhood cancers defy current understan...
Explainer: what is nanomedicine and how ...
Clinical trials and Lind’s ‘acid tes...
How parent's insights help my research
New leukaemia subtype found by DNA test
Joining the dots to find neuroblastoma d...
Neuroblastoma treatment search: polyamin...
Glowing report: firefly gene shows hidde...
Taking a walk inside a cancer cell
An Aussie anti-cancer drug success story
Profiler: what makes cancer cells’ met...
We need better treatment for childhood c...
Four seasons in one lab
Skeletons in cancer fight
Awareness Wednesday: Brain cancers
Targeting high-risk leukaemia subtypes
Awareness Wednesday: Leukaemia
Awareness Wednesday: Neuroblastoma
Robots play major role in tailoring trea...
Meet our researchers: Prof Maria Kavalla...
A way to target the Achilles heel of neu...



